- Home
- OBT vs VYGR Comparison
OBT vs VYGR Comparison
Compare OBT & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBT
- VYGR
- Stock Information
- Founded
- OBT 1892
- VYGR 2013
- Country
- OBT United States
- VYGR United States
- Employees
- OBT N/A
- VYGR N/A
- Industry
- OBT Major Banks
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- OBT Finance
- VYGR Health Care
- Exchange
- OBT Nasdaq
- VYGR Nasdaq
- Market Cap
- OBT 315.3M
- VYGR 342.5M
- IPO Year
- OBT N/A
- VYGR 2015
- Fundamental
- Price
- OBT $26.07
- VYGR $5.61
- Analyst Decision
- OBT Buy
- VYGR Strong Buy
- Analyst Count
- OBT 1
- VYGR 9
- Target Price
- OBT $35.50
- VYGR $15.53
- AVG Volume (30 Days)
- OBT 29.5K
- VYGR 344.7K
- Earning Date
- OBT 02-11-2025
- VYGR 02-26-2025
- Dividend Yield
- OBT 2.30%
- VYGR N/A
- EPS Growth
- OBT N/A
- VYGR N/A
- EPS
- OBT 2.56
- VYGR 0.47
- Revenue
- OBT $98,024,000.00
- VYGR $163,784,000.00
- Revenue This Year
- OBT N/A
- VYGR N/A
- Revenue Next Year
- OBT $4.83
- VYGR N/A
- P/E Ratio
- OBT $10.18
- VYGR $12.03
- Revenue Growth
- OBT 4.93
- VYGR 3.40
- 52 Week Low
- OBT $20.50
- VYGR $4.99
- 52 Week High
- OBT $33.06
- VYGR $10.66
- Technical
- Relative Strength Index (RSI)
- OBT 39.58
- VYGR 49.45
- Support Level
- OBT $25.92
- VYGR $5.32
- Resistance Level
- OBT $26.79
- VYGR $5.96
- Average True Range (ATR)
- OBT 0.97
- VYGR 0.28
- MACD
- OBT 0.09
- VYGR 0.06
- Stochastic Oscillator
- OBT 33.76
- VYGR 63.92
About OBT Orange County Bancorp Inc.
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.